A venture fund formed by a group of high net-worth individuals in China has offices in USA and China. The fund is currently seeking investment opportunities globally with a focus on China and the US. Projects based in Canada, Germany, and Switzerland may also be considered.
The fund pays close attention to investment opportunities from seed and early stages to growth stage. For seed and early stage projects, the fund makes investments in convertible notes and equity and is flexible on investment size. For growth stage projects, the fund makes equity investments of US$1-5 million in businesses with valuation of up to US$18-20 million. Due to its evergreen fund structure, the fund takes a long-term approach to investment. The fund typically syndicates in a financing round and would like to partner with local co-investors in case of overseas investments.
The firm focuses on high-growth fields in medical devices, diagnostics, digital health, and consumer products. The firm is agnostic to disease areas. In diagnostics, the fund is interested in portable imaging devices, high-intensity ultrasound, point-of-care diagnostics, and molecular diagnostics. In digital health, the fund is interested in technologies that can be applicable to the Chinese market, such as connected devices, telemedicine, and patient-physician platforms. In consumer products, the fund in interested in OTC, nutrition and dietary supplements that have proven efficacy and are on market.
The firm is looking to work with serial entrepreneurs from seed and early stages to growth stage to form complete and strong teams. The fund typically cooperates with local co-investors who play a supervisory role in overseas operations.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment